Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
9.27
+0.09 (0.98%)
At close: Aug 28, 2025, 4:00 PM
9.23
-0.04 (-0.43%)
After-hours: Aug 28, 2025, 4:00 PM EDT
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Anika Therapeutics stock has a target of 15, which predicts a 61.81% increase from the current stock price of 9.27.
Price Target: $15 (+61.81%)
Analyst Consensus: Buy
Analyst Ratings
According to 1 stock analyst, the rating for Anika Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $19 → $15 | Buy | Maintains | $19 → $15 | +61.81% | Jul 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +104.96% | May 12, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +115.75% | Mar 13, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +169.69% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +299.14% | Oct 22, 2024 |
Financial Forecast
Revenue This Year
113.22M
from 119.91M
Decreased by -5.58%
Revenue Next Year
119.26M
from 113.22M
Increased by 5.33%
EPS This Year
-1.16
from -3.83
EPS Next Year
-0.38
from -1.16
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 117.3M | 123.9M | |
| Avg | 113.2M | 119.3M | |
| Low | 108.2M | 113.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.2% | 9.4% | |
| Avg | -5.6% | 5.3% | |
| Low | -9.8% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.05 | 0.81 | |
| Avg | -1.16 | -0.38 | |
| Low | -1.25 | -1.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.